A 14-year-old spayed female Domestic Shorthair presents f...

Thank you for presenting this case. A 14-year-old spayed female Domestic Shorthair with IRIS Stage 3 CKD (BUN 80 mg/dL, Creatinine 3.5 mg/dL, SDMA 28 mcg/dL) and clinical signs of lethargy and poor appetite certainly warrants careful attention, particularly regarding pain management. Gabapentin is a valuable adjunct for neuropathic pain and chronic pain, and can also provide an anxiolytic effect, which may be beneficial for a cat experiencing chronic illness.

Given that gabapentin is almost exclusively renally excreted in cats, dose adjustment is indeed crucial in patients with advanced CKD to prevent accumulation and adverse effects. Starting with a conservative dose and monitoring closely is key.

For a feline patient with IRIS Stage 3 CKD, my recommendation for initiating gabapentin for pain management would be to reduce the dosing frequency significantly.

Recommended Gabapentin Dosing for Feline IRIS Stage 3 CKD:

* Initial Dose: 5-10 mg/kg orally every 24 hours (q24h).
* Practical Application: For many cats, this translates to administering 25-50 mg per cat orally every 24 hours (q24h).
* If using a 100 mg capsule, compounding to a lower dose or using a liquid formulation would be ideal to ensure accurate dosing and minimize side effects. If only 100mg capsules are available, consider administering 50mg (half capsule) q24h or even q48h initially.

Rationale and Monitoring:

Reduced Renal Clearance: In healthy cats, gabapentin's elimination half-life is approximately 3-4 hours. With significant renal impairment, this half-life will be substantially prolonged, leading to drug accumulation if standard dosing frequencies (q8-12h) are maintained.

Side Effects: The most common dose-limiting side effects of gabapentin in cats are sedation and ataxia. These are particularly undesirable in a cat already presenting with lethargy and poor appetite. Starting with a reduced frequency allows for slower accumulation and a better assessment of the patient's tolerance.

Titration: After initiating therapy, monitor the patient closely for 3-5 days. If the desired analgesic or anxiolytic effect is not achieved and the cat is tolerating the medication well (no excessive sedation or ataxia), you could consider:

* Increasing the dose slightly (e.g., from 25 mg to 50 mg q24h).
* Carefully reducing the interval to every 12-18 hours, but only if the patient is very tolerant and the clinical need is high. In IRIS Stage 3, I would be hesitant to go more frequently than q24h initially, especially in a cat that is already lethargic.

Oral Administration: Gabapentin can be bitter. Using compounded flavored liquids or administering capsules with a small amount of palatable food can improve compliance.

Addressing the "Why": While gabapentin helps manage pain, it is critical to continue addressing the underlying CKD and other potential contributors to lethargy and poor appetite, such as uremic gastritis, dehydration, or concurrent conditions like hypertension or anemia, which are common in advanced CKD.

In summary, for this patient, I would initiate gabapentin at 5-10 mg/kg (or 25-50 mg/cat) orally once daily. This conservative approach balances the need for pain control with the physiological limitations imposed by advanced renal disease.

Confidence Level: High confidence. This is a standard adjustment for renally excreted drugs in CKD patients.